|

Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas

RECRUITINGSponsored by National Cancer Institute, Naples
Actively Recruiting
SponsorNational Cancer Institute, Naples
Started2023-09-25
Est. completion2025-11-19
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06236464

Summary

This is a multicentric, retrospective, and prospective biomarker study.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

Patients aged ≥ 18 years, candidates for surgical treatment for squamous cell carcinoma of the anus, uterine cervix, vulva, and head-neck region (including microinvasive and invasive carcinomas) who are capable of understanding and willing to sign the informed consent form. Prospective patients must provide written informed consent before any procedures.

Exclusion Criteria:

Patients presenting any of the following criteria are not eligible for inclusion in this study. Exclusion criteria include:

1. Metastatic neoplasia
2. Treatment for other oncological pathologies
3. Congenital or acquired immunosuppression (HIV, organ transplant, pharmacological)

Conditions3

CancerSquamous Cell Carcinoma of the AnusSquamous Cell Carcinoma of the Head and Neck

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.